Zeus explores $4bn sale - report

Zeus is exploring the possibility of a $4 billion sale, according to a report from Reuters. 

The report says that the company is in the early stages of a sale process and is working with investment bank Goldman Sachs to establish whether a deal is financially attractive, adding that strategic buyers and private equity firms could be interested in a deal.

Zeus’s footprint in the medical device sector includes several vascular and non-vascular markets, producing permanently implantable or bioabsorbable device components, while also manufacturing components for catheters.

With its headquarters in Orangeburg, South Carolina, the company has bases in Ireland and China. 

Zeus declined to comment when approached by Med-Tech Innovation News for comment.